Summary by Moomoo AI
DEKI PHARMACEUTICALS CO., LTD. (THE “COMPANY”) HAS PUBLISHED ITS ANNUAL REPORT CIRCULAR AND NOTICE OF ANNUAL GENERAL MEETING FOR 2023. THE COMPANY'S COMMUNICATION DOCUMENT IS AVAILABLE IN CHINESE AND ENGLISH AND CAN BE ACCESSED ON THE UNITED STOCK EXCHANGE LIMITED AND ON OUR WEBSITE. In accordance with Section 2.07A of the Securities Listing Rules of the Hong Kong Stock Exchange Limited, with effect from 31 December 2023, the Company has adopted the electronic publication of the Company's communication documents, including Board reports, annual accounts, copies of auditor's reports, summaries of financial statements, interim reports, meeting notices, and listing Documents, Circulars and Proxy Forms, etc. The Company reminds non-registered shareholders that, if they need to receive printed corporate communications, they should provide an email address through the intermediary holding their shares or submit a request to the Company's Share Receipt Office in writing or by e-mail. The Company will provide a printed version of the documents as directed by shareholders for a period of one year.